CN Patent

CN115364218A — 一种特定药脂比的药物组合物在抗肿瘤中的应用

Assigned to Highfield Biopharmaceutical Corp · Expires 2022-11-22 · 3y expired

What this patent protects

本发明属于医药技术领域，具体涉及一种低药脂比(Drug to Lipid ratio，D/L)的抗肿瘤化疗药物脂质体及其应用。所述的低药脂比脂质体虽然在单位脂质材料的载药量方面低于上市和研发中化疗药物脂质体，但单位药物浓度下针对肿瘤细胞的药效却明显提高。

USPTO Abstract

本发明属于医药技术领域，具体涉及一种低药脂比(Drug to Lipid ratio，D/L)的抗肿瘤化疗药物脂质体及其应用。所述的低药脂比脂质体虽然在单位脂质材料的载药量方面低于上市和研发中化疗药物脂质体，但单位药物浓度下针对肿瘤细胞的药效却明显提高。

Drugs covered by this patent

Patent Metadata

Patent number
CN115364218A
Jurisdiction
CN
Classification
—
Expires
2022-11-22
Drug substance claim
No
Drug product claim
No
Assignee
Highfield Biopharmaceutical Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.